PAO Group Set to Debut First Pet CBD Products by Year End

PAO Group, Inc. has been working on the development of CBD products for pets and could have its first product ready to introduce before the end of the year, the company announced this week.

Last year, PAO Group, Inc. acquired intellectual property derived through research into CBD extracted in association with a patented extraction method (U.S. Patent No. 9,199,960). PAOG is developing both pharmaceutical and nutraceutical treatments for humans based on this intellectual property. Today, for the first time, the company revealed it is also developing CBD products for pets.

On Monday of this week, PAOG announced the launch of its first CBD nutraceutical product, RelaxRX CBD, a sleep aid.

The company plans to launch its second CBD nutraceutical product on Thursday this week, Oct. 21.

PAOG is on track to realize its first revenue this year, starting in Q4 2021, since acquiring the extraction technology.

PAOG has confirmed shipping its first and second CBD nutraceutical product to its distribution partner, North American Cannabis Holdings, Inc. The product will soon be for sale online at USMJ.

Learn more about PAOG here.